Literature DB >> 8273605

The corpus callosum: normal fetal development as shown by transvaginal sonography.

G Malinger1, H Zakut.   

Abstract

OBJECTIVE: Detection of the corpus callosum in the developing fetus on sonograms usually is difficult. We determined the normal appearance and development of this structure during the second half of pregnancy, as shown on transvaginal sonograms. SUBJECTS AND METHODS: One hundred one fetuses were evaluated with transvaginal sonography between 18 and 42 weeks' gestation. The length of the corpus callosum and the thicknesses of the genu, body, and splenium were measured, and growth tables were produced.
RESULTS: The corpus callosum was detected in 95% of cases and showed gradual enlargement during pregnancy; growth was linear, from nearly 17 mm in length at 18 weeks' gestation to 44 mm at term. The ratios of the length of the corpus callosum to the anteroposterior diameter of the brain remained relatively constant from 20 to 21 weeks' gestation to term.
CONCLUSION: Transvaginal sonography can be used to visualize and measure the corpus callosum in the developing fetus. Data from this study may be useful as a reference for normal development of the corpus callosum.

Mesh:

Year:  1993        PMID: 8273605     DOI: 10.2214/ajr.161.5.8273605

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  27 in total

1.  Corpus callosum length by gestational age as evaluated by fetal MR imaging.

Authors:  J H Harreld; R Bhore; D P Chason; D M Twickler
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

2.  Absent circle of Willis with vascular pollarding in an adult with colpocephaly: A developmental perspective.

Authors:  Peruvumba N Jayakumar; Renjan Verghese; Divyan Paul
Journal:  Neuroradiol J       Date:  2015-10-06

3.  Fetal cerebral biometry: normal parenchymal findings and ventricular size.

Authors:  C Garel
Journal:  Eur Radiol       Date:  2005-02-22       Impact factor: 5.315

4.  Prenatal magnetic resonance imaging: brain normal linear biometric values below 24 gestational weeks.

Authors:  C Parazzini; A Righini; M Rustico; D Consonni; F Triulzi
Journal:  Neuroradiology       Date:  2008-06-19       Impact factor: 2.804

5.  Biometry of the corpus callosum assessed by 3D ultrasound and its correlation to neurodevelopmental outcome in very low birth weight infants.

Authors:  K Klebermass-Schrehof; S Aumüller; K Goeral; K Vergesslich-Rothschild; R Fuiko; S Brandstetter; A Berger; B Jilma; N Haiden
Journal:  J Perinatol       Date:  2016-12-15       Impact factor: 2.521

6.  A New Ultrasound Marker for Bedside Monitoring of Preterm Brain Growth.

Authors:  J A Roelants; I V Koning; M M A Raets; S P Willemsen; M H Lequin; R P M Steegers-Theunissen; I K M Reiss; M J Vermeulen; P Govaert; J Dudink
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-17       Impact factor: 3.825

Review 7.  Prenatal neurologic anomalies: sonographic diagnosis and treatment.

Authors:  Luc De Catte; Bart De Keersmaeker; Filip Claus
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

8.  Brain microstructural development at near-term age in very-low-birth-weight preterm infants: an atlas-based diffusion imaging study.

Authors:  Jessica Rose; Rachel Vassar; Katelyn Cahill-Rowley; Ximena Stecher Guzman; David K Stevenson; Naama Barnea-Goraly
Journal:  Neuroimage       Date:  2013-10-01       Impact factor: 6.556

9.  Interhemispheric functional connectivity following prenatal or perinatal brain injury predicts receptive language outcome.

Authors:  Anthony Steven Dick; Anjali Raja Beharelle; Ana Solodkin; Steven L Small
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

10.  Abnormal interhemispheric connectivity in neonates with D-transposition of the great arteries undergoing cardiopulmonary bypass surgery.

Authors:  M Makki; I Scheer; C Hagmann; R Liamlahi; W Knirsch; H Dave; V Bernet; K Batinic; B Latal
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.